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        Introduction 
  Adhesion to ECM is primarily mediated by integrins, a family 
of heterodimeric receptors (  Hynes, 2002  ) that cluster into adhe-
sion sites. Focal adhesions (FAs) have been shown to form a 
scaffold that fi  rst sense and then transform extracellular cues 
into cellular responses and, in turn, transmit the contractile 
intracellular tensions to the ECM (  Bershadsky et al., 2003  ; 
  Ingber, 2003; Chen et al., 2004  ). Because of their involvement 
in cell motility and matrix remodeling, adhesion sites are 
necessarily dynamic structures that are able to assemble and 
disassemble. FA assembly takes place at the leading edge of 
membrane protrusions, whereas disassembly occurs both at the 
cell rear and at the base of protrusions. The molecular mecha-
nisms controlling FA turnover have been partly characterized. 
They require Rho family GTPases, integrin engagement, and 
coordinated interaction between integrins and structural/signaling 
molecules as well as actin-binding proteins, actin micro  fi  la-
ments, and microtubules (  Raftopoulou and Hall, 2004  ;   Webb 
et al., 2004; Ezratty et al., 2005  ). Talin, a direct cytoplasmic 
    integrin – binding protein, is involved in adhesion site for ma -
tion, reinforcement, and stabilization (  Albiges-Rizo et al., 
1995  ;   Priddle et al., 1998; Giannone et al., 2003  ;   Jiang et al., 
2003  ) as well as in integrin activation and local PIP  2   generation 
(  Martel et al., 2001  ;   Calderwood et al., 2002  ;   Tadokoro et al., 
2003  ). Integrin clustering requires the formation of complexes 
composed of activated integrins, immobilized ligands, talin, 
and PIP  2   (  Cluzel et al., 2005  ). Additionally, the calpain family 
regulates cell motility, partly by down-regulating integrin-
mediated adhesion complexes (  Bhatt et al., 2002  ) and through 
talin cleavage, a rate-limiting step during adhesion turnover, 
and is critical for FA disassembly (  Franco et al., 2004  ). The current 
understanding is that integrin-containing adhesion sites func-
tion as signal transduction centers. Consequently, tight regu-
lation of integrin affi  nity is crucial for adhesion signaling ( Bennett, 
2005  ). Integrins adopt high and low affi  nity conformations, 
and ligand  –  integrin binding is often preceded by intracellular 
changes, resulting in increased affi  nity ( Ginsberg et al., 2005 ). 
Crystal structure analysis suggests a bent, hooklike confor-
mation for the extracellular domain in the inactive state and 
an extended conformation in the active state (  Liddington and 
Ginsberg, 2002  ;   Takagi and Springer, 2002  ). Talin binding 
C
ell migration is an integrated process requiring the 
continuous coordinated assembly and disassembly 
of adhesion structures. How cells orchestrate adhe-
sion turnover is only partially understood. We provide evi-
dence for a novel mechanistic insight into focal adhesion 
(FA) dynamics by demonstrating that integrin cytoplasmic 
domain  –  associated protein 1 (ICAP-1) slows down FA 
assembly. Live cell imaging, which was performed in both 
  Icap-1    –  deﬁ  cient mouse embryonic ﬁ  broblasts and cells 
expressing active       1   integrin, shows that the integrin high 
afﬁ  nity state favored by talin is antagonistically controlled 
by ICAP-1. This afﬁ  nity switch results in modulation in the 
speed of FA assembly and, consequently, of cell spread-
ing and migration. Unexpectedly, the ICAP-1  –  dependent 
decrease in integrin afﬁ  nity allows cell sensing of matrix 
surface density, suggesting that integrin conformational 
changes are important in mechanotransduction. Our re-
sults clarify the function of ICAP-1 in cell adhesion and 
highlight the central role it plays in the cell  ’  s integrated 
response to the extracellular microenvironment.
  Cell adaptive response to extracellular matrix 
density is controlled by ICAP-1  –  dependent 
      1  -integrin afﬁ  nity 
    Ang  é  lique     Millon-Fr  é  millon  ,   
1,2,3       Daniel     Bouvard  ,   
1,2,3       Alexei     Grichine  ,   
2,4       Sandra     Manet-Dup  é    ,   
1,2,3       Marc R.     Block  ,   
1,2,3     
and   Corinne     Albiges-Rizo     
1,2,3     
   
1  Institut National de la Sant  é   et de la Recherche M  é  dicale U823,  
2  Universit  é   Joseph Fourier,  
3  Centre National de la Recherche Scientiﬁ  que, Equipe de Recherche 
Labellis  é  e 3148, and  
4  Cell Imaging Platform, Institut Albert Bonniot, 38042 Grenoble Cedex 9, France     JCB • VOLUME 180 • NUMBER 2 • 2008  428 
  Figure 1.       ICAP-1 loss induces the central redistribution of FAs and increases        1  -integrin clustering.   (A and B) Confocal images obtained with   Icap-1 
+/+     
and   Icap-1   
        /          MEF cells (A) or   Icap-1 
+/+    ,   Icap-1   
        /         , and   Icap-1 
rescue     osteoblasts (B). Cells were cultured overnight on 10   μ  g/ml FN and processed for 429  INTEGRIN AFFINITY AND FOCAL ADHESION DYNAMICS   •   MILLON-FR  É  MILLON ET AL.
immunoﬂ  uorescence labeling to visualize       1   integrin (9EG7), paxillin, and vinculin. Note the increased number of FAs at the cell surface underlying the 
main cell body in   Icap-1   
        /          MEF cells and osteoblasts and the exclusive peripheral distribution of adhesion sites in rescued osteoblasts. (C and D)   Icap-1 
+/+     
and   Icap-1   
        /          MEF cells were plated on 10   μ  g/ml FN and allowed to spread for 2 h. Immunostaining was processed to visualize vinculin, paxillin, and       1   
or       3   integrins. Confocal images of each cell type were acquired and subjected to image analysis with MetaMorph software. (C) The mean surface of       3   
or       1   integrins containing FA (top histogram) and the MFI of       1   and       3   integrins in vinculin-stained FAs (bottom histogram) were measured in   Icap-1 
+/+     and 
  Icap-1   
        /          MEF cells. Right images show       1   and       3   integrin  –  containing FAs in both cell types. (D) The ratio of the mean intensities of vinculin-, paxillin-, or 
talin-containing FAs normalized to       1   integrin was then estimated. Experiments were performed in duplicate, and at least 20 cells were analyzed for each 
immunostaining. Error bars indicate SD. Bars, 20   μ  m.     
disrupts a salt bridge between the      and      subunits, leading to 
integrin activation (  Luo et al., 2004  ;   Vinogradova et al., 2004  ). 
Evidence suggests that the binding of a complex including 
talin, Rap1-GTP  –  interacting adaptor molecule, Rap1, and 
vasodilator-stimulated phosphoprotein (VASP) to the integrin 
cytoplasmic tail is a common fi  nal step in integrin activation 
(  Han et al., 2006  ). 
  Among integrin partners, integrin cytoplasmic domain  –
  associated protein 1 (ICAP-1) encompassing a phosphotyrosine-
binding domain interacts specifi  cally with the cytoplasmic tail 
of    1  integrin at the membrane-distal NPXY motif. The increase 
of     1   integrin  –  dependent cell motility on fi  bronectin (FN) upon 
ICAP-1 overexpression (  Chang et al., 1997  ,   2002  ;   Zhang 
and Hemler, 1999  ) and cell rounding up after overexpression 
of a phosphomimetic mutant of ICAP-1 at the CaMKII site 
(  Bouvard and Block, 1998  ) suggest that ICAP-1 might regulate 
    1  -integrin function. Moreover, talin and ICAP-1 compete in 
vitro for integrin binding, and high ICAP-1 concentrations dis-
rupt FA (  Bouvard et al., 2003  ). ICAP-1 and     1   integrin are co-
localized at the leading edges of cells during the early stages 
of spreading (  Fournier et al., 2002  ). This facet of ICAP-1 in 
FA dynamics, which is obviously regulatory and transitory, 
prompted us to determine in more detail the role played by 
ICAP-1 in adhesion site dynamics. 
  In this study, we show that   Icap-1  – defi  cient mouse em-
bryonic fi  broblasts (MEFs) display defects in cellular spreading 
and migration correlating with the redistribution of FA, a modi-
fi  cation in FA dynamics, and an increase in integrin affi  nity. 
These defects could be mimicked by increasing either integrin 
affi  nity or the surface density of the underlying matrix. By mod-
ulating integrin affi  nity, ICAP-1 allows the cell to adapt its ad-
hesion strength and rate of migration to changes in the matrix 
surface density. These data point not only to the existence of 
specifi  c molecules involved in FA assembly or disassembly sig-
naling pathways but also to the control of FA assembly and ma-
trix sensing through the fi  ne-tuning of integrin affi  nity. 
  Results 
  ICAP-1 loss alters the distribution and 
morphometry of FA 
 To  fi gure out the role of ICAP-1 in FA dynamics, we compared 
the adhesive behavior of MEFs isolated from wild-type (WT) 
and   Icap-1  – defi  cient mice embryos as well as in WT,   Icap-1  –
  null, and   Icap-1   rescued osteoblasts. Immunostaining revealed 
paxillin- and     1   integrin  –  containing FAs to be distributed 
throughout the ventral cell surface in   Icap-1  – null  MEFs, 
whereas WT cells exhibited mostly peripheral FAs (  Fig. 1 A  ). 
In contrast, distribution of the     3   integrin (known not to interact 
with ICAP-1)  –  containing FA was not modifi  ed in   Icap-1  – null 
cells (Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200707142/DC1). FA distribution defects were ICAP-1 
dependent and not cell specifi  c because centrally located FAs in 
  Icap-1    –  null osteoblasts were redistributed peripherally after 
  Icap-1   rescue (  Fig. 1 B  ). This altered FA distribution was also 
associated with a modifi  cation of their morphometry.     1   integrin –
  containing FAs on FN were signifi  cantly larger in   Icap-1  – null 
fi  broblasts, whereas the size of     3   integrin – containing  FAs  re-
mained identical for both cell types (  Fig. 1 C  ).     1 -integrin  clus-
tering within FA, which was estimated by the mean fl  uorescence 
intensity (MFI), was increased by about twofold in   Icap-1  – null 
cells compared with WT cells (  Fig. 1 C  ). Then, we analyzed the 
putative role of ICAP-1 in the regulation of FA composition 
(  Fig. 1 D  ). Talin, vinculin, and paxillin as well as surface     1   and 
    3   integrins were expressed at similar levels in both cell types 
(Fig. S1, B and C). Constant adaptor protein/integrin ratios in 
both cell types indicates that ICAP-1 did not interfere with FA 
constitution and reveals that     1   integrins highly clustered within 
FA in null cells are fully competent to bind their intracellular 
partners (  Fig. 1 D  ). Thus, the increased size of FAs in   Icap-1  –
  null MEFs could be attributed to increased     1 -integrin  cluster-
ing and not to an indirect change in adhesion protein expression 
or to a modifi  cation in the cell surface expression of     3   and  
  1   integrins. 
    Icap-1    –  null cells exhibit a shift in the 
optimum ECM surface density required for 
cell migration and spreading 
  As the modifi  cation in the FA pattern and morphometry refl  ects 
cell adhesion and migratory defects, we monitored the migra-
tion rate of MEFs spread on increasing concentrations of 
    1   integrin  –  engaging matrices, FN and type I collagen (CL). 
The typical bell-shaped curve observed for WT cells was shifted 
toward the lower densities of ECM substrates for   Icap-1  –  d e fi cient 
cells. Indeed, the optimal matrix concentration required for the 
maximum migration of   Icap-1  –  d e fi cient cells was reduced 10-fold 
and 20-fold for FN and CL coatings, respectively (  Fig. 2 A  ). 
A very similar result was obtained with FN using time-lapse 
video microscopy (  Fig. 2 B  ). 
  Because migratory properties were modifi  ed in   Icap-1  –
  null MEFs, we investigated the consequences of ICAP-1 loss on 
cell spreading. The densities required to reach similar spreading 
levels on both matrices were much lower with   Icap-1  – null  cells 
than with WT cells. Indeed, with FN, 50% spreading was 
achieved at a 0.5-  μ  g/ml coating concentration for   Icap-1  – null 
cells versus 1   μ  g/ml for WT cells (  Fig. 2 C  ). Similar results 
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  Figure 2.       ICAP-1 loss shifts the optimum substrate concentration for migration and facilitated adhesion.   (A) The migration of   Icap-1 
+/+     and   Icap-1   
        /          MEF 
cells was studied in a random chemotactic transwell assay. Cells were seeded in transwell chambers coated on both sides with increasing concentrations 
of FN or CL ranging from 0.5 to 20   μ  g/ml. After 8 h, cell migration was stopped, and cells were stained and ﬁ  xed by Coomassie blue. The cells local-
ized on the underside of the membrane were counted, and the number of cells per ﬁ  eld was used to quantify cell migration. (B) The migration speed of 
  Icap-1 
+/+     and   Icap-1   
        /          MEF cells was determined on various FN concentrations by using time-lapse phase-contrast video microscopy and cell tracking 
with MetaMorph software. 20  –  40 cells were photographed for each experimental condition at 4-min intervals over an 8-h period. The maximal migration 
speed was used to set up 100% for each cell type. (A and B) Error bars indicate SD of at least thee individual experiments. (C and D) Spreading assay of 
  Icap-1 
+/+     and   Icap-1   
        /          MEF cells (C) as well as   Icap-1 
+/+    ,   Icap-1   
        /         , and   Icap-1   
rescue   osteoblasts (D) on increasing substrate densities. Cells were seeded 431  INTEGRIN AFFINITY AND FOCAL ADHESION DYNAMICS   •   MILLON-FR  É  MILLON ET AL.
on various concentrations of FN- or CL-coated surfaces and were allowed to spread for 1 h 30 min. Round and ﬂ  attened cells were counted, and spread 
cells were expressed as the percentage of total cell number. The inset represents the same spreading assay with increasing concentrations of     FN. Each data 
point represents the mean of at least three separate experiments, and error bars represent SD. *, P   ≤   0.03.     
        
were obtained with CL: 50% spreading occurred at a coating 
concentration of 5   μ  g/ml for   Icap-1  – null  cells  compared  with 
25   μ  g/ml for WT cells (  Fig. 2 C  ).   Icap-1  – null  cells  appeared  to 
exhibit a stronger interaction with FN and CL and, consequently, 
spread at lower densities of these ECM substrates. In both mi-
gration and spreading assays, the differences between WT and 
mutant cells were more pronounced using CL. This probably 
refl  ects the more restricted use of     1   integrins on CL. On the 
other hand, the expression of ICAP-1 in   Icap-1  – null  MEFs  re-
stores cell spreading and migration similarly to what was ob-
served for WT MEFs (Fig. S2, A and B; available at http://www
.jcb.org/cgi/content/full/jcb.200707142/DC1), proving that the 
altered migration was indeed caused by the loss of endogenous 
ICAP-1. A similar effect was also observed with osteoblasts: at 
the FN-coating concentration of 0.3   μ  g/ml, the totality of   Icap-1  –
  null osteoblasts were fully spread, whereas only 50% of WT 
and rescued osteoblasts were spread under identical experimen-
tal conditions, demonstrating that this defect was still ICAP-1 
dependent but not cell specifi  c (  Fig. 2 D  ). In agreement with 
the specifi  city of ICAP-1 for     1   integrin, migration and adhe-
sion behaviors of WT and   Icap-1  – null  MEFs  on  vitronectin 
(VN) coating were not signifi  cantly different. This demonstrates 
that ICAP-1 loss did not alter     3   integrin – mediated  adhesion 
(Fig. S3, A and B). 
  ICAP-1 slows down the talin recruitment 
into FAs 
  The fact that   Icap-1    –  null cells migrated and spread at lower ma-
trix densities might refl  ect defects in adhesion dynamics. If ICAP-1 
was involved in FA dynamics, differences are expected in the 
exchange or recruitment rate of some FA components between 
  Icap-1    –  null cells and WT cells. To address this point, measure-
ments of FRAP experiments were made using EGFP-fused vin-
culin or talin ( Fig. 3 ). Single FA in the lamella was photobleached, 
and their fl  uorescence recovery was recorded. Recovery times (   ) 
were calculated for both fusion proteins. Our results revealed that 
EGFP-vinculin recruitment was four times faster than EGFP-talin 
in WT MEF cells spread on FN ( Fig. 3 A ). However, no difference 
between WT and   Icap-1  –  d e fi cient MEFs was observed in the in-
corporation speed of EGFP-vinculin into FAs, demonstrating that 
vinculin recruitment is ICAP-1 independent. Conversely, the re-
covery half-time associated with EGFP-talin was signifi  cantly 
lower in   Icap-1  –  d e fi cient MEFs, suggesting a faster recruitment 
of EGFP-talin in cells lacking ICAP-1. This conclusion is in line 
with the proposed competitive binding of ICAP-1 and talin for the 
    1  -integrin cytoplasmic domain (  Bouvard et al., 2003  ). FRAP 
experiments were also performed in cells spread on     3 -integrin 
preferential substrate, such as VN to compare talin and vinculin 
recruitment in case of   Icap-1   defi  ciency (  Fig. 3 B  ). As expected, 
no signifi  cant change in talin recruitment was observed in both 
cells spread on VN. Our results demonstrate that the function of 
ICAP-1 is dependent on adhesion on specifi  c substrate. 
  ICAP-1 slows down FA assembly 
  Two key steps in cell migration are FA assembly and disassem-
bly (  Webb et al., 2004  ). To identify whether ICAP-1 was in-
volved in FA turnover, WT and   Icap-1  – null  MEF  cells  expressing 
EGFP-paxillin, EGFP-vinculin, or EGFP-VASP were moni-
tored using time-lapse video microscopy over a 6-h period. 
Again, we noticed that EGFP-VASP (  Fig. 4 A  ), EGFP-paxillin, 
or EGFP-vinculin (not depicted) expressed in   Icap-1  – null  cells 
were mostly localized in central FAs. Cells were plated on a low 
concentration of FN (1   μ  g/ml) to promote cell migration. Turn-
over of FAs located at the leading edge were arbitrary decom-
posed into four parameters: namely, assembly (from the fi  rst 
appearance until the maximal pixel intensity level is reached), 
steady-state duration (no change of the maximal pixel inten-
sity), disassembly rates (from the maximum pixel intensity is 
  Figure 3.       ICAP-1 loss induces a faster recruitment of talin into FAs.     Icap-1 
+/+     
and   Icap-1   
        /          MEF cells were seeded in LabTekII chambers coated with 
either 20   μ  g/ml FN (A) or 5   μ  g/ml VN (B) and were allowed to spread 
for 12 h. After transfection, both cell types expressing either EGFP-talin or 
EGFP-vinculin were subjected to FRAP experiments. Photobleaching was 
performed on manually delimited individual FAs localized at the edge of 
cells. EGFP ﬂ  uorescence recovery was measured at 1-min intervals over a 
15  –  20-min period, and the characteristic recovery time (    ) of each FA pro-
tein was estimated. At least 20 FAs were recorded for both cell types. Error 
bars indicate SD. The shorter recovery time,     , of EGFP-talin in   Icap-1   
        /          
cells indicates a higher mobility of this protein (e.g., its faster recruitment 
into FA). *, P   ≤   0.01.     JCB • VOLUME 180 • NUMBER 2 • 2008  432 
  Figure 4.       ICAP-1 modulates FA turnover by controlling its assembly rate.   (A) Confocal images of   Icap-1 
+/+     and   Icap-1   
        /            MEF cells either immunostained 
to visualize endogenous paxillin or transfected to express EGFP-VASP. (B  –  F)   Icap-1 
+/+     and   Icap-1   
        /          MEF cells expressing either EGFP-paxillin, EGFP-
vinculin, or EGFP-VASP were allowed to spread on 1   μ  g/ml FN for 12 h in a LabTekII chamber. Then, cells were imaged by time-lapse video microscopy 
at 4-min intervals for 6 h. The resulting data were subjected to image analysis using MetaMorph software. The mean pixel intensity of a deﬁ  ned FA was 
followed over time, and this analysis allowed the four parameters of FA turnover to be measured: measurement of the positive (B) or negative (C) variations 
per minute of the mean pixel intensity reﬂ  ecting the assembly and disassembly rates, respectively, for each individual FA in   Icap-1 
+/+     and   Icap-1   
        /          cells; 433  INTEGRIN AFFINITY AND FOCAL ADHESION DYNAMICS   •   MILLON-FR  É  MILLON ET AL.
in     1 -integrin  affi  nity. Indeed, the activation state of     1   in-
tegrins measured by FACS revealed a higher affi  nity state in 
  Icap-1    –  null cells than in WT cells (  Fig. 6 A  ). This result is 
consistent with our recent work showing an increase in     5    1 -
integrin affi  nity in osteoblasts issuing from   Icap-1  – null  mice 
(  Bouvard et al., 2007  ) and also suggests that this integrin af-
fi  nity increase is cell type independent. To correlate the in-
crease in     1 -integrin  affi  nity to the adhesive defect observed in 
  Icap-1    –  null cells, integrins were chemically activated in WT 
cells to mimic the   Icap-1    –  null phenotype (  Fig. 6, B and C  ; 
and Fig. S4, available at http://www.jcb.org/cgi/content/full/
jcb.200707142/DC1). Mn 
2+   treatment of both WT and res-
cued cell types shifted the spreading curve toward lower FN 
or CL surface densities, whereas it had no effect on Mn 
2+ -
treated   Icap-1    –  null cells because their integrins are already 
in a high affi  nity state (  Figs. 6 B   and S4, A and B). These 
results were also confi  rmed with 9EG7 mAb, which is able to 
both recognize an activated     1   integrin – specifi  c epitope and 
maintain it in its high affi  nity conformation (  Figs. 6 C   and S4 C). 
Thus, it was tempting to speculate that     1 -integrin  affi  nity 
could also control FA assembly. To test this hypothesis, we 
generated the activated     1  -integrin mutant D759A with a dis-
rupted salt bridge between      and      subunits (  Hughes et al., 
1996  ;   Sakai et al., 1998; Partridge et al., 2005  ) and expressed 
it in     1   integrin – defi  cient GD25 cells. First, we confi  rmed 
that GD25/    1  D759A cells displayed a higher affinity for 
the FNIII7-10 fragment than GD25/    1  WT cells (  Fig. 7 A  ). 
At moderate FN surface densities, FAs were centrally distributed 
in GD25/    1  D759A cells, whereas they were located on the 
periphery in control cells (  Fig. 7 B  ). Both adhesive and mi-
gratory curves displayed a shift toward the lower matrix den-
sities in mutant cells (  Fig. 7 C  ). The coating concentration 
of FN giving the highest migration speed was approximately 
fi  ve times lower for GD25/    1  D759A cells. Mn 
2+   treatment  of 
GD25/    1  WT integrin cells induced a shift in the spreading 
curve and mimicked the adhesive behavior of GD25/    1 D759A 
and   Icap-1  – null  cells.  Finally,  GD25/   1  D759A cells displayed 
a faster rate of FA assembly, which is associated with a shorter 
lifetime, without any signifi  cant modifi  cation in the duration of 
the steady state or the disassembly rate (  Fig. 7 D  ). Altogether, 
these results suggest that the adhesive defect in   Icap-1  – null 
cells was the result of the presence of     1   integrin in its active 
state and further implicate     1  -integrin activation in the regula-
tion of FA assembly. 
  Control of          1  -integrin afﬁ  nity by ICAP-1 
allows ECM density sensing 
  The reduced amount of adsorbed matrix required to support cell 
migration or spreading observed for   Icap-1  – null  cells  suggests 
that the sensing of matrix surface density has been changed. 
Moreover, the activation of     1   integrin displaces the maximal 
reached until FA is not resolvable), and total lifetime (from the 
fi  rst appearance of a resolvable FA until its disappearance). 
In   Icap-1    –  null cells, the increase in EGFP-tagged protein intensity 
during FA assembly was signifi  cantly faster (  Fig. 4, B and F  ), 
and the duration of the steady state was slightly shorter ( Fig. 4 D ) 
than for WT cells. In contrast, FA disassembly rates (  Fig. 4, 
C and F  ) were identical for both cell types. These measurements 
showed that faster FA assembly associated with a minor reduc-
tion of the steady state upon ICAP-1 loss results in a shorter FA 
lifetime (  Fig. 4, E and F  ). It is worth noting that this change in 
dynamics was not observed with   Icap-1   
   /          cells spread on VN, 
thus underlining the action of ICAP-1 on     1   integrins (Fig. S3 C). 
Altogether, these data suggest that ICAP-1 down-regulates 
cell migration and spreading by slowing down FA assembly in-
volving     1   integrins. 
  ICAP-1 is not required for FA disassembly 
  Previous work has highlighted an important role for micro-
tubule networks in FA turnover (  Kaverina et al., 1999; Ezratty 
et al., 2005  ). This is based on the fi  nding that microtubule de-
polymerization upon nocodazole treatment increases FA assem-
bly, whereas microtubule regrowth after nocodazole washout 
induces a rapid and reversible disassembly of FA. We took ad-
vantage of the synchronized disassembly of FAs induced by no-
codazole to investigate the involvement of ICAP-1 in the control 
of this process. After 4 h of nocodazole treatment, the micro-
tubule network totally collapsed, and WT MEFs displayed 
larger peripheral FAs ( Fig. 5, A and B ). However,  Icap-1  –  d e fi cient 
MEFs showed a dramatic increase in the number of central FAs, 
whereas the number and size of peripheral FAs were not signifi  -
cantly changed (  Fig. 5, A and B  ). For both cell types, 60 min 
after nocodazole washout, FA disassembly temporally coincided 
with de novo growth of microtubules toward the cell periphery. 
FA reappeared 90 min after nocodazole washout, showing that 
FA disassembly was reversible in both cell types. Quantifi  cation 
of our observations revealed that nocodazole treatment of   Icap-1  –
  null cells induced the de novo formation of central but not pe-
ripheral FAs. In contrast, WT MEFs behaved differently because 
nocodazole induced a reinforcement of existing peripheral 
FAs without promoting de novo assembly (  Fig. 5 B  ). Along 
with the video microscopy experiments, these results consis-
tently suggested that ICAP-1 loss favored FA assembly but had 
no infl  uence on disassembly. 
  Increased integrin afﬁ  nity in   Icap-1    –
  deﬁ  cient cells is responsible for the cell 
adhesion phenotype 
  As ICAP-1 competes with talin for     1   cytoplasmic domain 
binding (  Bouvard et al., 2003, 2007  ), the promotion of FA as-
sembly resulting in the modifi  cation in migration and spread-
ing of   Icap-1  – null  fi  broblasts could arise from an increase 
the time during which the mean pixel intensity did not ﬂ  uctuate corresponds to the FA steady state (D); and the total time during which EGFP-fused adhesion 
proteins remain localized in a FA represents the FA lifetime (E). At least 20 cells of both cell types were recorded. Each point represents an individual FA, 
and the horizontal bars are the mean of all FAs. (F) These four parameters were compiled in a schematic model of FA turnover in   Icap-1 
+/+     and   Icap-1   
         /           
cells. The higher FA assembly rate in   Icap-1   
        /          cells and the reduced steady-state duration induced the shortening of FA lifetime. *, P   <   0.05; **, P   <   10 
4  ; 
***, P   <   10 
6  . Bar, 20   μ  m.     
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  Figure 5.       ICAP-1 loss induces de novo FA formation upon nocodazole treatment.   (A)   Icap-1 
+/+     and   Icap-1   
        /          MEF cells were either untreated or treated 
with 10   μ  M nocodazole for 4 h or treated with 10   μ  M nocodazole for 4 h followed by the drug washout for 60 and 90 min and were ﬁ  xed. FA and 
microtubules were visualized by immunostaining of vinculin (green) and tyrosinated tubulin (red) and imaged using confocal microscopy. (B) Image quan-
tiﬁ  cation of vinculin-stained   Icap-1 
+/+     and   Icap-1   
        /          cells. Peripheral (left) or central (right) FA number per cell was counted (top) at each indicated step of 
the nocodazole assay, and the corresponding mean surface (bottom) was quantiﬁ  ed. 20 cells were analyzed for each experimental condition, and error 
bars indicate SD. Bar, 20   μ  m.     435  INTEGRIN AFFINITY AND FOCAL ADHESION DYNAMICS   •   MILLON-FR  É  MILLON ET AL.
adhesive response to a signifi  cantly lower matrix concentration, 
suggesting that ICAP-1 is involved in the cell  ’  s perception and 
response to its microenvironment. We hypothesized that in-
creasing substrate density would affect adhesion strength and 
favor the active state of the integrin. Indeed, WT MEFs on low 
density matrices showed only peripheral FAs (  Fig. 8 A  ). At high 
matrix density, the observed increase in FA number distributed 
throughout the ventral cell surface was correlated with an in-
crease in activated     1  -integrin recruitment into FAs (  Fig. 8, 
B and C  ). However, in   Icap-1    –  null MEFs, FAs were mostly 
distributed all over the ventral face regardless of the matrix 
density used. These results reveal that increasing substrate den-
sity induces     1   integrin to take up its high affi  nity state and, 
furthermore, that ICAP-1 loss renders cells unable to sense the 
state of the matrix and adapt to variations in ECM density. 
  To assess whether the reduction in the adhesive response 
of   Icap-1    –  null cells to matrix density could be attributed to 
some differential adhesion dynamics, we quantifi  ed FA turn-
over in cells at different FN matrix densities using time-lapse 
video microscopy (  Fig. 8 D  ). In WT cells, increased matrix den-
sity (10  –  50   μ  g/ml) induced faster FA assembly. A similar effect 
was observed using   Icap-1    –  null cells but at lower FN-coating 
densities. This result supported our hypothesis that matrix den-
sity affects FA assembly and that   Icap-1  – null  cells  can  only 
poorly adapt their adhesive structures to increase in ECM den-
sity because of their already high adhesion strength at low ma-
trix density. However, we noticed a rise in the length of the 
steady-state phase at higher matrix densities in both WT and 
null cells, suggesting that the control of FA dynamics during the 
stages after assembly is ICAP-1 independent but matrix density 
dependent. These results highlight the involvement of ICAP-1 
in sensing the state of the matrix through control of FA assem-
bly, thus enabling the cell to adapt its adhesive response to changes 
in properties of the ECM. 
  Discussion 
  In this study, we have used both   Icap-1  – defi  cient MEFs and ac-
tive     1  -integrin mutants to show that the regulation of integrin 
affi  nity is necessary for the control of FA assembly and, con-
sequently, also for cell spreading and cell migration. Our data 
demonstrate that ICAP-1 slows down FA assembly by decreasing 
    1 -integrin  affi  nity. We also document a new and unexpected 
role for ICAP-1 in the regulation of integrin affi  nity for a proper 
matrix surface density sensing. Therefore, ICAP-1 belongs to 
the molecular machinery of the FA that is able to provide the 
cell with the ability to respond adaptively to changes in sub-
strate density. 
  Our present work provides an array of convergent clues in 
support of a critical role for ICAP-1 in the control of FA turn-
over. Indeed, the faster assembly rate of FA in the lamella of 
  Icap-1    –  null cells accelerates the maturation state of the adhe-
sion and is associated with a slightly shorter steady state, resulting 
in a reduced lifetime. However, as the rate of FA disassembly is 
not modifi  ed by the lack of ICAP-1, this strongly suggests that 
disassembly is triggered by an ICAP-1  –  independent signal-
ing pathway. Although some proteins such as paxillin and FAK 
  Figure 6.              1  -integrin activation induces a spreading phenotype similar to 
ICAP-1 loss.   (A) The       1  -integrin activation state in   Icap-1 
+/+     and   Icap-1   
        /          
cells was determined by an FNIII7-10 binding assay that measures the 
ability of integrins to bind FITC-conjugated FNIII7-10 by ﬂ  ow cytometry 
analysis as described in Materials and methods. The activation index of 
integrin was expressed relative to the cell surface expression of       1   integrin 
as previously estimated by ﬂ  ow cytometry using MB1.2 mAb. (B and C) 
Spreading assays of   Icap-1 
+/+     and   Icap-1   
        /          MEF cells with or without 
treatment using either 0.5 mM MnCl  2   (B) or with 10   μ  g/ml 9EG7 mAb (C). 
Cells were ﬁ  rst treated in suspension and were plated in a dose-dependent 
manner on FN. Cell spreading was measured as described in   Fig. 2 C  . 
Error bars indicate SD from three independent experiments.     JCB • VOLUME 180 • NUMBER 2 • 2008  436 
  Figure 7.       Activated        1   integrin increases FA turnover and promotes cell migration and spreading at low matrix density.   The human WT       1  -integrin chains 
or activated mutant (D759A) were stably expressed in       1   integrin  –  deﬁ  cient GD25 cells, and their adhesive properties were analyzed. (A) The integrin af-
ﬁ  nity state for both cell types was measured with the FNIII7-10 binding assay as described in   Fig. 6 A  . (B) Confocal images of GD25/WT and D759A       1   
cells spread on 10   μ  g/ml FN and immunostained to visualize       1   integrin, paxillin, and ﬁ  lamentous actin.       1   integrin was labeled with the 4B7R mAb, which 
recognizes the human       1  -integrin chain. (C) Cell spreading and migration assays of GD25/WT and D759A       1   cells. Spreading of both cells types with or 
without 0.5 mM MnCl  2   treatment was measured as described in   Fig. 6 B  . Migration of both cells types was analyzed using time-lapse phase-contrast video 437  INTEGRIN AFFINITY AND FOCAL ADHESION DYNAMICS   •   MILLON-FR  É  MILLON ET AL.
are involved in FA disassembly (  Webb et al., 2004  ;   Schober 
et al., 2007  ;   Zaidel-Bar et al., 2007  ), to date, ICAP-1 is the only 
regulatory molecule shown so far to negatively control the as-
sembly phase. The specifi  c interaction of ICAP-1 with the 
    1   integrins (  Chang et al., 1997  ) combined with the change in 
the adhesion properties of   Icap-1    –  null cells, depending on the 
integrin-engaging substrates, indicate that the observed modi-
fi  cation in FA dynamics in these cells probably involves the 
participation of     1   integrins. 
 Modifi  cation in the dynamics of     1   integrin – containing 
FAs in   Icap-1    –  null cells is also revealed by the faster recruit-
ment of EGFP-talin into FAs observed by FRAP studies. This 
observation in living cells fi  ts with in vitro talin  –  ICAP-1 com-
petition assays as well as with the FA disruption and cell 
rounding up occurring after ICAP-1 overexpression. Although 
FRAP experiment could not defi  nitively measure the increase 
of the on-rate of talin into FA, these results support the idea 
that ICAP-1 competes with talin for binding to the     1   cytosolic 
tail (  Bouvard and Block, 1998  ;   Bouvard et al., 2003  ). We pro-
pose that ICAP-1 can delay the talin  –  integrin interaction nec-
essary for integrin activation and clustering (  Giannone et al., 
2003; Calderwood, 2004  ;   Cluzel et al., 2005  ). This also sug-
gests that by modulating talin  –  integrin interaction, ICAP-1 
could limit the incorporation of     1   integrins into FAs, resulting 
in a modifi  cation in FA dynamics. However, we cannot ex-
clude that the faster recruitment of talin into FA in   Icap-1 –  null 
cells could be correlated with increased FAK or Src signaling 
in the     1   integrin  –  enriched FA. This could also indicate an al-
teration in the affi  nity of talin for     1   integrin, resulting in the 
overall instability of FAs and their faster FA turnover. Our FACS 
analysis of fl  uorescent FNIII7-10 binding on cells in suspen-
sion show that the loss of ICAP-1 increases the affinity of 
integrin for the ligand, although not as much as is achieved 
by incubation with either with Mn 
2+   or 9EG7 antibody. This 
favors the hypothesis whereby ICAP-1 limits a state of pre-
activation necessary for the following steps of activation. With-
out ICAP-1, this limitation is switched off, which, in turn, 
accelerates cellular mechanisms such as spreading or migra-
tion. Interestingly, when cells spread or migrate, any means of 
integrin activation (D/A, ICAP-1 loss, or chemical treatment) 
results in the same phenotype. This fi  ts with our observation 
that D/A and   Icap-1    –  null cells share the same phenotype but 
also suggests that either a threshold in integrin activation ex-
ists or that integrin activation is tightly controlled in space and 
time by a multistep process, implying different integrin states 
from preactivation to full activation of integrin as already sug-
gested (  Clark et al., 2005  ). Moreover, FA distribution in the 
cell central region is cell type specifi  c because     1   integrin – 
defi  cient osteoblasts infected with D759A human     1   integrin 
display more FA in the cell central region compared with 
GD25/    1  D759A cells (unpublished data). 
microscopy and cell tracking as described in   Fig. 2 B  . (D) GD25 cells stably expressing EGFP-zyxin and either WT       1   or D759A integrin were spread on 
5   μ  g/ml FN and monitored by time-lapse video microscopy at 4-min intervals for 6 h. FA dynamics were assessed as described in   Fig. 4  . Four parameters 
for FA located at the leading edge of migrating cells were measured: assembly and disassembly speed, steady-state duration, and lifetime. Horizontal bars 
are the mean of all FAs. Error bars indicate SD. *, P   <   10 
5  . Bar, 20   μ  m.     
        
  Although the control of the     1 -integrin  high  affi  nity state 
has been well characterized and is largely attributed to the inter-
action with talin (  Calderwood, 2004  ), the mechanisms restricting 
    1   integrin in a low affi  nity state are still unknown. Here, we 
show that ICAP-1 loss results in increased     1 -integrin  affi  nity in 
MEFs, as previously described for osteoblasts (  Bouvard et al., 
2007  ). Importantly, this increase of     1 -integrin  affi  nity in   Icap-1  –
  null cells results in faster FA turnover and in the inability 
of the cells to adapt their adhesive properties. This abnormal 
switch of     1   integrins toward the high affi  nity state results in 
maximal cell spreading and migratory response on a coating of 
minimal substrate density even though no migration defect has 
been noticed in   Icap-1    –  null mice during embryogenesis. Never-
theless, we can neither exclude the presence of a more subtle 
defect nor exclude the possibility of a migration defect in   Icap-1  –
  null mice during repair or pathogenesis. Mice expressing a 
D759A mutation in     1   locus have been recently described 
(  Czuchra et al., 2006  ). In contrast to   Icap- 1 – null  mice,  those 
animals do not display signifi  cant abnormalities (  Czuchra et al., 
2006  ). However, although talin binding onto     1   integrin is re-
quired for its full activation in both mutants, the absence of 
ICAP-1 expression would favor talin binding, whereas ICAP-1 
would still limit this step in the case of the D/A mutation. It is 
also important to note the discrepancy of adhesive phenotype 
between keratinocytes isolated from D/A mice (  Czuchra et al., 
2006 )  and   Icap-1 –   null cells, which could arise from the different 
integrin repertoires between mesenchymal cells (MEFs or osteo-
blasts) and epithelial cells (keratinocytes). Furthermore,   Icap-1  –
 defi  cient mice also suffer from a strong osteoblast proliferation 
defect that could be integrin independent (  Bouvard et al., 2007  ). 
  However, our results indicate that a balance between low 
and high affi  nity integrin states is necessary for proper sensing 
of the ECM density, which, in turn, has important consequences 
for migration and spreading. Cell adhesion is continually adapted 
in response to changes in substrate concentration and structure 
or to mechanical cues at the cell  –  matrix interface. Distinct FA 
and actin cytoskeleton organization and dynamics have been 
shown to depend on the strength of cell adhesion (  Gupton and 
Waterman-Storer, 2006  ). Our data provide new insight by adding 
integrin affi  nity regulation to the molecular mechanisms con-
trolling these different processes. Change in adhesive properties 
can be predicted on the basis of the redistribution of FA. In our 
study, the hallmark of increased integrin affi  nity, corresponding 
to the signature of cellular adaptation to a particular matrix en-
vironment, is the redistribution of FA throughout the ventral 
cell surface accompanied by an expansion in their areas. These 
central FAs do not display the characteristics of fi  brillar adhe-
sions and are not correlated with an increased capacity to 
deposit FN matrix (unpublished data). Cells lacking ICAP-1 
are much less capable of sensing different matrix densities; con-
sequently, maximal response is elicited by a minimum matrix JCB • VOLUME 180 • NUMBER 2 • 2008  438 
  Figure 8.       ICAP-1 loss decreases matrix density sensing.   (A)   Icap-1 
+/+     and   Icap-1   
        /          MEF cells were allowed to spread on glass coverslips coated or 
not coated (control) with increased FN concentrations in FCS-containing medium and were immunostained to visualize vinculin and       1   integrin (9EG7). 
Images were taken with a confocal microscope. (B and C) The number of vinculin-stained FAs/cell (B) and the MFI of       1  -integrin staining within FAs 
(C) were measured for each FN concentration. 50 cells were analyzed for each experimental condition, and error bars indicate SD. (D) EGFP-paxillin  – 
expressing   Icap-1 
+/+     and   Icap-1   
        /          MEF cells were spread on FN at concentrations ranging from 1 to 50   μ  g/ml and were recorded by time-lapse video 
microscopy at 4-min intervals for 6 h. FA turnover was quantiﬁ  ed as previously described in   Fig. 4  : the rates of FA assembly and disassembly were 
determined as well as the duration of the steady state and total lifetime at three different FN densities (1, 10, and 50     g/ml). Data from at least 20 
cells per experimental condition were recorded. Each point represents a single FA, and the horizontal bars show the means of all FAs. These parameters 
were compiled in a schematic model of FA turnover in   Icap-1 
+/+     and   Icap-1   
        /          cells. Adhesion site turnover displays different behaviors depending 
on matrix density. Note the appearance of a steady-state plateau in both cell types at high FN concentrations without any change in FA lifetime. Error 
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density environment. Cell adaptive response and stem cell lin-
eage specifi  cation may arise from substrate stiffness (  Discher 
et al., 2005  ;   Paszek et al., 2005; Engler et al., 2006  ). This in-
ability to feel their environment has important consequences for 
in vivo function. Indeed,   Icap-1    –  null mice suffer from an im-
portant osteogenesis dysfunction resulting from reduced prolif-
eration and delayed differentiation of the osteoblast population. 
  Icap-1  – defi  cient preosteoblasts present a condensation defect 
that further limits the number of progenitors that will fi  nally 
differentiate into mature osteoblasts (  Bouvard et al., 2007  ). This 
cell compaction defect could be a consequence of the cells  ’   
inability to sense the matrix density or organization. The pro-
nounced phenotype in osteoblasts may be caused by their 
extraordinary need for mechanosensitivity to mediate bone for-
mation and remodeling along with the necessity of being aware 
of the inherent variability in cellular response to differences in 
matrix density or stiffness (  Leucht et al., 2007  ). Although it is 
clear from previous work that     1  -integrin expression is crucial 
for development and tissue homeostasis, we clearly establish 
that a switch between high and low affi  nity integrin states is re-
quired to drive an integrated cell response that is appropriate for 
the ECM environment. This is achieved by specifi  c integrin reg-
ulators such as talin, ICAP-1, and possibly other proteins that 
are central to the control of FA dynamics during cell adhesion. 
  Materials and methods 
  Reagents and antibodies 
  FN was extracted from human plasma (  Albiges-Rizo et al., 1995  ). Rat CL 
was purchased from Roche, and VN was purchased from Becton Dickinson. 
Vinculin mAb (hVIN-1), actin pAb (AC40), talin mAb (8d4), and phalloi-
din-rhodamine were obtained from Sigma-Aldrich. Paxillin mAb (349) was 
purchased from BD Biosciences. Anti  –  human       1  -integrin mAb (4B7R) was 
obtained from Lab Vision Corp. Anti  –  mouse       1  -integrin 9EG7 and MB1.2 
mAb were obtained from BD Biosciences and provided by M.C. Bosco 
(University of Western Ontario, Ontario, Canada), respectively. Anti  –
  mouse       3  -integrin mAb was provided by B. Nieswandt (Rudolf Virchow 
Center, University of W  ü  rzburg, W  ü  rzburg, Germany). Tyrosinated tubulin 
pAb was provided by L. Lafenach  è  re (Unit  é   Mixte de Recherche     5168, 
Grenoble, France). AlexaFluor-conjugated goat antibodies were purchased 
from Invitrogen. Rabbit anti  –  ICAP-1 serum was raised by immunizing rab-
bits with puriﬁ  ed recombinant His-tagged ICAP-1 (amino acids 1  –  150) as 
antigen. Goat anti  –  mouse IgG and goat anti  –  rabbit IgG coupled to HRP 
were purchased from Bio-Rad Laboratories and Jackson ImmunoResearch 
Laboratories, respectively. 
  Cell culture, transfection, retroviral infection, and plasmid construction 
  Primary MEFs were isolated from embryonic day 14.5 WT or   Icap-1    –  deﬁ  cient 
embryos using a standard procedure. Immortalized osteoblasts from   
Icap-1 
+/+     and   Icap-1    –  null mice as well as   Icap-1    –  null osteoblasts rescued 
with   Icap-1   were generated as described previously (  Bouvard et al., 2007  ). 
MEF, GD25, and osteoblast cells were cultured in DME supplemented with 
10% FCS (Invitrogen) and 100 U/ml penicillin/100   μ  g/ml streptomycin at 
37  °  C in a 5% CO  2  -humidiﬁ  ed chamber. Cells were transfected with the 
cDNA constructs using ExGen 500 (Euromedex). The expression vectors 
were pEGFP-C1-vinculin, pEGFP-C1-paxillin (provided by K. Nakamura, 
Osaka Bioscience Institute, Osaka, Japan), pEGFP-C1-talin (provided by 
A. Huttenlocher, University of Wisconsin, Madison, WI), pBabe       1  -WT, 
pBabe       1  (D759A), pBabe-EGFP-VASP (provided by F. Gertler, Massachu-
setts Institute of Technology, Cambridge, MA), and pCLMFG-IRES  –  ICAP-1. 
Retroviral plasmid encoding human WT       1   integrin or the D759A mutant 
was performed using standard protocols. In brief, a HindIII subclone frag-
ment was used for PCR-mediated mutagenesis using the QuikChange Site-
Directed Mutagenesis kit (Stratagene) according to the manufacturer  ’  s 
instructions and was reinserted into the full sequence to swap the WT se-
quence using HindIII digest. Human WT or mutant       1   integrin was then in-
serted into the pBabe retroviral vector using EcoRI and XhoI sites. All sequences 
were veriﬁ   ed by DNA sequencing (Genome Express).       1   Integrin  –  null 
GD25 cells were transfected with pBabe containing either WT or D759A 
      1   integrin and were selected in the presence of 1   μ  g/ml puromycin. 
For retroviral infection, cells were incubated for 24 h at 37  °  C with either 
pBabe-EGFP-VASP, pCLMFG-Ires  –  ICAP-1, or pCLMFG-EGFP-zyxin retrovirus 
containing supernant in 10% FCS-DME and 4   μ  g/ml Polybrene (Sigma 
Aldrich) as previously described (  Bouvard et al., 2007  ). 
  Western blotting 
  MEF cells were lysed in radioimmunoprecipitation assay buffer containing 
protease and phosphatase inhibitors (Roche). Proteins were separated by 
SDS-PAGE and transferred to polyvinylidene diﬂ  uoride membranes. Immuno-
logical detection was achieved with appropriate HRP-conjugated second-
ary antibody. Peroxidase activity was visualized by chemiluminescence (ECL; 
GE Healthcare). 
  Immunoﬂ  uorescence staining of cells 
  Cells were ﬁ  xed with 4% PFA, permeabilized with 0.2% Triton X-100, and 
incubated with appropriate primary antibodies. After rinsing, coverslips 
were incubated with an appropriate AlexaFluor-conjugated secondary anti-
body. The cells were mounted in Mowiol/DAPI solution and imaged on an 
inverted confocal microscope (LSM510; Carl Zeiss, Inc.). 
  Spreading assays 
  Cell adhesion assays were performed using 35-mm-diameter hydrophobic 
dishes coated with various concentrations of matrix. Cells were trypsinized, 
treated with 1 mg/ml trypsin inhibitor (Sigma-Aldrich), and incubated in 
serum-free DME/5% BSA for 1 h at 37  °  C. Cells were plated at a density 
of 2   ×   10 
4   cells per dish in 2 ml DME containing FN-free 10% FCS. After 
1.5 h of incubation at 37  °  C, cells were photographed and scored as round 
or ﬂ  attened using three ﬁ  elds for each experimental condition. When Mn 
2+   
was supplemented, cells were treated for 10 min at 37  °  C in suspension with 
0.5 mM MnCl  2   in DME containing FN-free FCS before seeding. Alter-
natively, cells were treated with 10   μ  g/ml mAb(9EG7) for 30 min at 4  °  C in 
DME containing FN-free FCS. 
  Migration assays 
  For transwell assays, polycarbonate membranes (8-  μ  m pores; BD Bio-
sciences) were coated on both sides overnight with various concentrations 
of matrix. After washing with PBS, chambers were transferred in 24-well 
plates containing either serum-free DME or DME plus FN-free serum. Serum-
starved cells were trypsinized and treated with trypsin inhibitor. 15   ×   10 
3   
cells were seeded in the upper chamber in 1 ml of serum-free DME and al-
lowed to migrate to the underside of the membrane for 8 h. Cell migration 
was stopped by ﬁ  xing and staining with Coomassie blue. Excess dye was 
removed with isopropanol/acetic acid. After removal of the nonmigrating 
cells in the upper well, migrating cells were photographed at 10  ×   magniﬁ  -
cation and counted using three randomly chosen microscopic ﬁ  elds. 
  Time-lapse video microscopy was performed using chambered cover-
glass (LabTekII; Thermo Fisher Scientiﬁ  c) coated with various concentrations 
of FN. Trypsinized cells were treated with trypsin inhibitor and incubated in 
5% BSA for 1 h at 37  °  C. Cells were then plated in LabTekII chambers con-
taining DME supplemented with FN-free serum. After 1 h of spreading, cells 
were observed at 10  ×   magniﬁ  cation using an inverted microscope (Axiovert 
100; Carl Zeiss, Inc.) equipped with an on-stage incubator (XL-3; PeCon). 
Six to eight isolated ﬁ  elds were arbitrary chosen, and phase-contrast images 
were taken at 4-min intervals over a period of 5 h. Cells were tracked using 
the position of centroids with MetaMorph software (Roper Scientiﬁ  c). 
  FNIII7-10 binding assay and ﬂ  ow cytometry analysis 
  MEF or GD25 cells were harvested after trypsin treatment, washed in the 
presence of trypsin inhibitor, and incubated (3   ×   10 
5   cells per sample) with 
3     M FITC-coupled FNIII7-10 fragment (provided by F. Coussin, Unit  é   
Mixte de Recherche 5017, Bordeaux, France) in Tyrode buffer supple-
mented with 1% BSA for 1 h in the presence or absence of 5 mM EDTA and 
5 mM EGTA. After washing with Tyrode/BSA, the cells were ﬁ  xed and sub-
jected to ﬂ  ow cytometry analysis using a FACScan ﬂ  ow cytometer (BD Bio-
sciences). The collected data were analyzed using CellQuest software (BD 
Biosciences). In parallel, MEF or GD25 cells were analyzed by FACS for 
cell surface       1  - or       3  -integrin expression using either the MB1.2 rat mAb 
(against mouse       1   integrin), the 4B7R mouse mAb (against human       1   
integrin), or the anti  –  mouse       3  -integrin rat mAb (against mouse       3   integrin). 
The activation index of       1   integrin was estimated as previously described 
(  Bouvard et al., 2007  ). Each speciﬁ  c MFI was calculated by subtracting the 
background obtained with FnIII7-10 fragment incubation in the presence of 
EDTA or without the primary antibody in the case of the integrin labeling. JCB • VOLUME 180 • NUMBER 2 • 2008  440 
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For instance, for the estimation of human       1  -integrin activation (GD25 
cells), activation index = ([MFI FnIII7-10]    [MFI FnIII7-10 + EDTA])/([MFI 
4B7R]    [MFI 4B7R control]). 
  Nocodazole assay 
  Cells were serum starved for 48 h in DME containing 0.5% fatty acid  –  free 
BSA and were treated with 10     M nocodazole for 4 h to completely depo-
lymerize microtubules. The drug was washed out with serum-free DME me-
dium containing 0.5% fatty acid  –  free BSA, and microtubules were allowed 
to repolymerize for different time intervals. Cells were ﬁ  xed and permeabi-
lized before processing for immunoﬂ  uorescence. 
  Quantiﬁ  cation of FA area and intensity 
  Fixed and stained cells were imaged on a nonlinear optics LSM510 
inverted confocal and biphoton laser-scanning microscope equipped with 
a 63  ×   NA 1.4 oil-immersion plan Apochromat objective (Carl Zeiss, Inc.). 
The ﬂ   uorescence of AlexaFluor488 and 546 was excited with 488- 
or 543-nm wavelengths and detected in confocal mode. AlexaFluor350 
ﬂ  uorescence was induced by two-photon absorption at 720 nm using the 
fs Ti-Sa laser (Tsunami; Spectra-Physics). Neither signal saturation nor 
signiﬁ  cant photobleaching was induced during image acquisition in either 
detection channel. 
  The images were manually thresholded, and FAs were automatically 
selected using MetaMorph software within the predeﬁ  ned regions of the 
cell. The number and areas of FAs and the MFIs of       1  ,       3   integrin, vinculin, 
and paxillin in FAs were quantiﬁ  ed. 
  Time-lapse video microscopy and quantiﬁ  cation of FA dynamics 
  Time-lapse recordings were assessed either on MEF cells expressing EGFP-
paxillin, EGFP-VASP, or EGFP-vinculin and on GD25 cells expressing EGFP-
zyxin. Cells were cultured in FN-free FCS-DME on LabTekII chambers 
previously coated with the indicated concentrations of matrix. Living cells 
were maintained at 37  °  C in a 5% CO  2   atmosphere under an inverted 
micro  scope (Axiovert 200M; Carl Zeiss, Inc.) equipped with a motorized 
stage, cooled CCD camera (CoolSNAP HQ2; Roper Scientiﬁ  c), and a live 
cell imaging plan Apochromat 63  ×   NA 1.2 water immersion objective 
(Carl Zeiss, Inc.). To minimize the possible photobleaching and light-
induced cell damage, the excitation light of a 100-W Hg lamp was reduced 
to 30% with a FluoArc system (Carl Zeiss, Inc.) and additionally attenuated 
with a ﬁ  lter (ND75; Carl Zeiss, Inc.). 15 isolated cells were randomly cho-
sen for each experimental condition, and 10  –  15 control WT cells were re-
corded simultaneously. Images were acquired, looping all stage positions 
at 4-min intervals over 6 h. The turnover of FAs located at the cell front was 
quantiﬁ  ed using MetaMorph software. In brief, the adhesion area was out-
lined on the raw images during steady state, and then adhesion was manu-
ally followed from its nucleation. The MFI in the same area was measured, 
subtracting the background value. Four parameters of adhesion turnover 
were determined: the total lifetime, the period of steady state, and the rates 
of assembly and disassembly. 
  FRAP 
  MEF cells transiently expressing EGFP-talin or EGFP-vinculin were cultured 
on LabTekII chambers (Thermo Fisher Scientiﬁ  c) previously coated with ei-
ther 20   μ  g/ml FN or 5   μ  g/ml VN. FRAP experiments were performed with 
an LSM510 confocal microscope equipped with the on-stage incubator. 
One individual FA per cell located at the leading edge was processed by 
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  Online supplemental material 
  Fig. S1 shows the distribution of       3   integrin containing FAs and the ex-
pression of adhesion proteins in WT and   Icap-1    –  null MEF cells. Fig. S2 
shows the spreading and migration on increased FN matrix densities of 
WT,   Icap-1  –    null, and rescued   Icap-1  –    null MEF cells. Fig. S3 illustrates 
the adhesive behavior (cell migration, spreading, and FA dynamics) of 
WT and   Icap-1  –    null MEF cells spread on VN, a       3   integrin  –  speciﬁ  c 
matrix. Fig. S4 shows that       1  -integrin activation in WT MEFs and rescued 
  Icap-1    –  null osteoblasts induces a similar spreading to   Icap-1    –  null cells. 441  INTEGRIN AFFINITY AND FOCAL ADHESION DYNAMICS   •   MILLON-FR  É  MILLON ET AL.
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